Hmga1 protein could be an important therapeutic target for osteoporosis

New research published in The FASEB Journal indicates that increasing the expression of a particular gene may help to prevent bone loss associated with postmenopausal osteoporosis.

Henry Schein expects cyber incident costs to continue in 2024

By the numbers Q4 sales: $3 billion 12% decrease year over year Q4 net income: $18 million Compared to $47 million in Q4 2022 A

February 27, 2024

Could mutated blood cells hold the key to lower Alzheimer’s risk?

Researchers tested whether clonal hematopoiesis of indeterminate potential (CHIP) status was associated with Alzheimer’s disease.

June 19, 2023

Secarna Pharmaceuticals publishes new data in Nucleic Acid Therapeutics showcasing strategies to detect and prevent immunostimulatory potential of LNA-modified ASOs – Biotech Investments

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Scientific publication Secarna Pharmaceuticals publishes new data in Nucleic Acid Therapeutics showcasing strategies to detect

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.